This is a prospective feasibility study. The aim of this work is to assess the acceptability and feasibility of optical diagnosis-led care in bowel cancer screening patients undergoing colonoscopy. This study will determine whether bowel cancer screening colonoscopists are able to consistently record and diagnose diminutive adenomas suitable for a resect and discard strategy allowing assignment of surveillance intervals according to Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) criteria. A practical quality assurance program around optical diagnosis will be introduced. The use of a CAD polyp-detection system will also be evaluated (AI-DETECT).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Learning curve to achieve accurate optical diagnosis
Timeframe: Through study completion, approximately 18-24 months
Proportion of cases where optical diagnosis derived surveillance intervals concur with histopathology derived surveillance intervals
Timeframe: 2 weeks for each participant
Polyp detection rate (AI-DETECT)
Timeframe: 2 weeks for each participant